The Changes of CD4+T Lymphocyte Subsets in Septic Patients
NCT01494389 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2011-12-19
Summary
The purpose of this study is to explore the value of CD4+T lymphocyte subsets in cell immunity in the patients with sepsis.There are immunoparalysis in septic patients,the important player is the change of CD4+T lymphocyte,this immunoparalysis state contribute to the illness progress and outcome. Comprehend the change regularity of septic patients' cell immunity can guide fiter and correcter treatment.
Conditions
- Sepsis
- SIRS(Systemic Inflammatory Response Syndrome)
Sponsors & Collaborators
-
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
Xie Li Xin, Doctor · Department Of Respiratory Diseases, Chinese PLA General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-03-31
Countries
- China
Study Locations
More Related Trials
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
NCT02883218 ·Status: COMPLETED
-
Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms
NCT03379896 ·Status: UNKNOWN
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Expression and the Clinical Significance of Neutrophil PD-L1 During Sepsis
NCT01976884 ·Status: COMPLETED
-
CD64 and Antibiotics in Human Sepsis
NCT02922998 ·Status: COMPLETED
-
Immune Profile of Patients With Sepsis
NCT04163705 ·Status: UNKNOWN
-
Immunoregulatory Therapy for 2019-nCoV
NCT04268537 ·Status: UNKNOWN ·Phase: PHASE2
-
Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han Population
NCT01504243 ·Status: UNKNOWN
-
Analysis of Immune Response In Bacterial Infection of Obese Subject
NCT02882568 ·Status: COMPLETED ·Phase: NA
-
The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis
NCT01649921 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis
NCT02180009 ·Status: COMPLETED
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Platelet-associated Inflammation in Severe Sepsis
NCT03029039 ·Status: COMPLETED
-
Expression of TIM-3 on Lymphocytes in Sepsis
NCT02319876 ·Status: UNKNOWN
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
Assessing Immune Dysfunction in Sepsis
NCT07154615 ·Status: RECRUITING
-
Sepsis Characterization in Kilimanjaro
NCT05139459 ·Status: COMPLETED
-
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962 ·Status: UNKNOWN
-
Descriptive Study of the Evolution in Proportion of Regulatory B Lymphocytes in Patients Hospitalized in Intensive Care for Severe Sepsis
NCT03115125 ·Status: UNKNOWN ·Phase: NA